Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 204.55

+0.5%

1:17 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andrew H who wrote (9788)	10/21/1997 12:53:00 AM
From: Henry Niman	Read Replies (2) of 32384

<<7." LLY will also receive worldwide exclusive rights in certain areas to LGND's PPAR technology." Would you guess we are talking metabolic and cardiovascular only here? Any idea what kinds of royalties we are talking?>> I assume its for screening LLY's library for PPARalpha specific compounds for cardiovascular and obsity, and PPARgamma specific compounds for type II diabetes. What most posters fail to understand is the importance of this agreement to LLY. They are using LGND's technnology to move their research into the next mellinium. LGND will harness an extraordinary share of LLY's R&D budget for developing potent oral treaments for several metabolic diseases, including but certainly not limited to diabetes. It was NOT a coincidence that LGND and LLY were on CNBC today, nor was it a coincidence that the deal was announced on the same day as LLY's earnings.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next